Using Rhodamine 123 Accumulation in CD⁸⁺ Cells as a Surrogate Indicator to Study the P-Glycoprotein Modulating Effect of Cepharanthine Hydrochloride In Vivo

Table 2

Body weights of the animal after treatment.

Treatment groups	Body weights (g)
	Day 1	Day 4	Day 8
FAP+CH 10.0 mg/kg	25.9 ± 1.4	25.6 ± 1.3	25.1 ± 1.2
FAP+CH 5.0 mg/kg	25.2 ± 1.6	25.0 ± 1.6	24.7 ± 1.8
FAP+CH 2.5 mg/kg	25.0 ± 1.9	24.5 ± 1.9	23.8 ± 2.1
FAP+VER 2.5 mg/kg	25.1 ± 1.2	25.0 ± 1.1	24.3 ± 1.3
FAP	25.5 ± 1.8	24.6 ± 1.7	24.6 ± 1.5
CH 10.0 mg/kg	24.9 ± 1.3	25.0 ± 1.0	24.9 ± 0.9
Control	25.3 ± 1.2	25.8 ± 1.4	26.9 ± 1.9